The drug giving new life to cystic fibrosis patients
For years, a diagnosis of cystic fibrosis has often meant an early death for patients. This week, Cystic Fibrosis Canada released its annual data report this week for 2021. A new drug, Trikafta, is keeping patients out of hospitals and off of transplant lists. The Globe’s health reporter Kelly Grant explains why doctors are now talking about cystic fibrosis as a disease in transition and the hope of a new future for thousands of patients.
Audio is streamed directly from the publisher (afp-119681-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
For years, a diagnosis of cystic fibrosis has often meant an early death for patients. This week, Cystic Fibrosis Canada released its annual data report this week for 2021. A new drug, Trikafta, is keeping patients out of hospitals and off of transplant lists.
The Globe’s health reporter Kelly Grant explains why doctors are now talking about cystic fibrosis as a disease in transition and the hope of a new future for thousands of patients.
Questions? Comments? Ideas? Email us at [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.